ABOUT JAVELIN
Javelin Medical is the medical device company that makes the Vine™ Embolic Protection System, advancing a new approach to stroke prevention in high-risk AF patients.
Our Mission
Reducing the burden of recurrent ischemic stroke by addressing a critical gap in today’s standard of care. Despite widespread use of oral anticoagulants, many patients with Atrial Fibrillation remain at significant risk of stroke due to emboli that reach the brain.
At the core of our platform is the Vine™ Embolic Protection System, a novel permanent carotid implant designed to capture emboli traveling toward the cerebral circulation and prevent them from causing stroke.
About WHRI
World Health Research Institute (WHRI) brings together researchers, clinicians, and project teams with expertise across a broad range of fields, including brain health and stroke, arrhythmia, thrombosis, and cardiovascular disease prevention. WHRI serves as the INTERCEPT study management organization.
INTERCEPT Study- Enrolling Now
The INTERCEPT study is actively enrolling patients in the USA, Europe and Canada, Enrollment will soon commence also in South America.
Sites Participating
Countries Participating
Armenia | Argentina | Belgium | Brazil | Canada | Chile | Colombia | Czech Republic Georgia | Germany | Greece | Italy | Mexico | Poland | Portugal | Spain | Switzerland United Kingdom | USA | Uzbekistan
Join the Comprehensive Stroke Prevention Revolution
"*" indicates required fields
Investigational device, limited by United States law to investigational use.